BioMarin Pharmaceutical
BMRN
#2068
Rank
S$12.36 B
Marketcap
S$63.98
Share price
0.57%
Change (1 day)
-16.84%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): S$0.49 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$3.24 Billion. In 2025 the company made an earning of S$0.61 Billion a decrease over its 2024 earnings that were of S$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.49 B-20.55%
2025 S$0.61 B-10.94%
2024 S$0.69 B187.31%
2023 S$0.24 B26.07%
2022 S$0.19 B-298.51%
2021 -S$96.52 Million78.04%
2020 -S$54.22 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.19 Billion297.78%
2017 -S$45.96 Million-95.68%
2016 -S$1.07 Billion437.12%
2015 -S$0.2 Billion23.91%
2014 -S$0.16 Billion-29.25%
2013 -S$0.23 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$55.89 Million103.01%
2010 -S$27.53 Million-3903.54%
2009 S$0.72 M-98.31%
2008 S$42.81 M-189.7%
2007 -S$47.73 Million51.02%
2006 -S$31.61 Million-61.58%
2005 -S$82.26 Million-56.59%
2004 -S$0.19 Billion95.13%
2003 -S$97.1 Million12.09%
2002 -S$86.63 Million73.19%
2001 -S$50.02 Million18.32%
2000 -S$42.28 Million19.65%
1999 -S$35.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$9.80 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.69 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.14 Billion-128.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.15 Million-107.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.36 B-26.47%๐Ÿ‡บ๐Ÿ‡ธ USA